Results 31 to 40 of about 25,566 (257)

Effect of Awareness Program on Newly Mothers' Knowledge and Practices Regarding Neonatal Jaundice [PDF]

open access: yesEgyptian Journal of Health Care
Background: Newborns are at a much-increased risk of neonatal jaundice due to the relative adverse effects of neonatal hyperbilirubinemia. Aim: This study aimed to evaluate the effect of awareness program on newly mothers' knowledge and practices ...
Magda Ahmed Abd El Aziz   +3 more
doaj   +1 more source

The Effect of Low Birthweight on the Incidence of Neonatal Jaundice in Sidoarjo

open access: yesJurnal Berkala Epidemiologi, 2018
Background : The incidence of neonatal jaundice on low birth weight babies (BBLR) are mostly lead to mortality. A preliminary survey in the neonatal room of the public hospital (RSUD) Sidoarjo in January to December 2013 showed that there were 391 (12 ...
Ndaru Puspita
doaj   +1 more source

Differential diagnosis of neonatal jaundice [PDF]

open access: yes, 2016
Jaundice is one of the most common symptoms of the neonatal period which in most cases is not associated with a serious illness. For example, jaundice in healthy newborns which does not affect the child's development.
A. N. Goryainova   +8 more
core   +2 more sources

Expanded Hepatic Progenitor Cells Featured with Aggregation of α‐Synuclein Contribute to Pathologic Bile Duct Regeneration in Biliary Atresia

open access: yesAdvanced Science, EarlyView.
Expanded NCAM1+EpCAM+ hepatic progenitor cells in biliary atresia are characterized by aggregation of α‐synuclein. This pathological protein potentiates cellular susceptibility to GSH‐dependent redox dyshomeostasis, induces unstable biliary cell fate specification, and subsequently drives aberrant biliary regeneration.
Hua Xie   +12 more
wiley   +1 more source

Jaundice and its associated factors among neonates admitted to selected referral hospitals in southwest oromia, Ethiopia: Multi-center cross-sectional study

open access: yesHeliyon, 2023
Background: Jaundice is a common clinical problem during the first month of birth throughout the world. Mainly, it is the leading cause of neonatal morbidity and mortality in developing countries.
Gutu Belay   +5 more
doaj   +1 more source

Histidine Supplementation Stabilizes Hearing and Vision and Improves Growth in HARS1‐Related Autosomal Recessive Disorder Associated With Usher‐Like Symptoms

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Autosomal recessive HARS1‐related disorder (originally described as Usher syndrome type 3B) caused by a homozygous Y454S variant in the histidyl‐tRNA synthetase gene (HARS1) is characterized by progressive sensorineural hearing and vision loss and respiratory deterioration with risk for sudden death following febrile illnesses.
Victoria Mok Siu   +23 more
wiley   +1 more source

Neonatal Jaundice: A Study on the Incidence in Children of Rh (D) Negative and 0 Rh (D) Positive Mothers

open access: yesActa Medica
Despite advances in neonatal care, neonatal jaundice remains a common problem in maternity wards. The present retrospective epidemiological study collected data on a sample of 710 newborns and compared the incidence of neonatal jaundice in infants born ...
Josef Urbanec   +4 more
doaj   +1 more source

Genotype–Phenotype Correlations of Monoallelic PFIC Variants in Pediatric Liver Disease: A Multicenter Retrospective Cohort Study

open access: yesAmerican Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Progressive familial intrahepatic cholestasis (PFIC) is classically caused by biallelic pathogenic variants, yet monoallelic variants of uncertain significance (VUS) in PFIC‐associated genes are increasingly identified in children with cholestasis, creating diagnostic uncertainty.
Brett J. Hoskins   +9 more
wiley   +1 more source

The epidemiology of neonatal jaundice. [PDF]

open access: yes, 2021
Neonatal jaundice (NJ) is one of the most common causes for medical intervention in the newborn period. While transitory hyperbilirubinemia (HB) is present in almost all newborns, detection of jaundice requires a trained observer and good lighting. Thus,
Hansen, Thor Willy Ruud
core   +1 more source

UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI‐PGx)

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Irinotecan, a topoisomerase I inhibitor, is available as both non‐pegylated and pegylated formulations. The non‐pegylated formulation is licensed for use in advanced colorectal cancer either in combination with other agents or as monotherapy.
Dharmisha Chauhan   +24 more
wiley   +1 more source

Home - About - Disclaimer - Privacy